Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 17, 2006

France Investment Program Launched to Finance Innovative SMEs

  • France Investissement, an equity investment scheme focused on small and medium sized businesses, has been launched.

    With some Euro$300 million per year over six years committed to the program by pivotal funding engine, the state-controlled investment bank, Caisse des Dépôts (CDC), France Investissement should enable approximately x3 billion to be plowed into innovative and/or high-growth potential SMEs.

    The scheme, which also includes contributions from private investors, is primarily focused on the establishment and development of independent, innovative SMEs (where R&D spend accounts for over 15 percent of total corporate costs) and high-growth potential SMEs.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »